Cardiologists’ Expectations of Aortic Valvuloplasty
In recent years, aortic stenosis and mitral regurgitation have stolen the limelight from other forms of valvular disease. However, treatment of aortic regurgitation (AR) has made solid advancements, of which the greatest have been the improved outcomes for aortic valvuloplasty, which has already become a practical option in a few institutions.
- 2.Puskas J, Gerdisch M, Nichols D, Quinn R, Anderson C, Rhenman B, et al., PROACT Investigators. Reduced anticoagulation after mechanical aortic valve replacement: interim results from the prospective randomized on-X valve anticoagulation clinical trial randomized Food and Drug Administration investigational device exemption trial. J Thorac Cardiovasc Surg. 2014;147:1202–10.CrossRefGoogle Scholar
- 3.Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, et al., RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013;369:1206–14.Google Scholar